Author Response: Stress Responsive Mir-31 is a Major Modulator of Mouse Intestinal Stem Cells During Regeneration and Tumorigenesis
Ye Tian,Xianghui Ma,Cong Lv,Xiaole Sheng,Xiang Li,Ran Zhao,Yongli Song,Thomas Andl,Maksim V. Plikus,Jinyue Sun,Fazheng Ren,Jianwei Shuai,Christopher J. Lengner,Wei Cui,Zhengquan Yu
DOI: https://doi.org/10.7554/elife.29538.044
2017-01-01
Abstract:Article Figures and data Abstract eLife digest Introduction Results Discussion Materials and methods References Decision letter Author response Article and author information Metrics Abstract Intestinal regeneration and tumorigenesis are believed to be driven by intestinal stem cells (ISCs). Elucidating mechanisms underlying ISC activation during regeneration and tumorigenesis can help uncover the underlying principles of intestinal homeostasis and disease including colorectal cancer. Here we show that miR-31 drives ISC proliferation, and protects ISCs against apoptosis, both during homeostasis and regeneration in response to ionizing radiation injury. Furthermore, miR-31 has oncogenic properties, promoting intestinal tumorigenesis. Mechanistically, miR-31 acts to balance input from Wnt, BMP, TGFβ signals to coordinate control of intestinal homeostasis, regeneration and tumorigenesis. We further find that miR-31 is regulated by the STAT3 signaling pathway in response to radiation injury. These findings identify miR-31 as a critical modulator of ISC biology, and a potential therapeutic target for a broad range of intestinal regenerative disorders and cancers. https://doi.org/10.7554/eLife.29538.001 eLife digest Cells lining the inner wall of the gut help to absorb nutrients and to protect the body against harmful microbes and substances. Being on the front line of defense means that these cells often sustain injuries. Specialized cells called intestinal stem cells keep the tissues healthy by replacing the damaged and dying cells. The intestinal stem cells can produce copies of themselves and generate precursors of the gut cells. They also have specific mechanism to protect themselves from cell death. These processes are regulated by different signals that are generated by the cell themselves or the neighboring cells. If these processes get out of control, cells can easily be depleted or develop into cancer cells. Until now, it remained unclear how intestinal stem cells can differentiate between and respond to multiple and simultaneous signals. It is known that short RNA molecules called microRNA play an important role in the signaling pathways of damaged cells and during cancer development. In the gut, different microRNAs, including microRNA-31,help to keep the gut lining intact. However, previous research has shown that bowel cancer cells also contain high amounts of microRNA-31. To see whether microRNA-31 plays a role in controlling the signaling systems in intestinal stem cells, Tian, Ma, Lv et al. looked at genetically modified mice that either had too much microRNA-31 or none. Mice with too much microRNA-31 produced more intestinal stem cells and were able to better repair any cell damage. Mice without microRNA-31 gave rise to fewer intestinal stem cellsand had no damage repair, but were able to stop cancer cells in the gut from growing. The results showed that microRNA-31 in intestinal stem cells helps the cells to divide and to protect themselves from cell death. It controlled and balanced the different types of cell signaling by either repressing or activating various signals. When Tian et al. damaged the stem cells using radiation, the cells increased their microRNA-31 levels as a defense mechanism. This helped the cells to survive and to activate repair mechanisms. Furthermore, Tian et al. discovered that microRNA-31 can enhance the growth of tumors. These results indicate that microRNA-31 plays an important role both in repairing gut linings and furthering tumor development. A next step will be to see whether cancer cells use microRNA-31 to protect themselves from chemo- and radiation therapy. This could help scientists find new ways to render cancerous cells more susceptible to existing cancer therapies. https://doi.org/10.7554/eLife.29538.002 Introduction The intestinal epithelium is one of the most rapidly renewing tissues, undergoing complete turnover in approximately 3 days (Leblond and Walker, 1956). This rapid turnover protects against insults from bacterial toxins and metabolites, dietary antigens, mutagens, and exposure to DNA damaging agents including irradiation. Upon insult, the rapid intestinal regeneration is particularly important as impaired regeneration can result in epithelial barrier defects that can lead to rapid dehydration and translocation of intestinal microbiota into the bloodstream. The processes of normal tissue turnover and intestinal regeneration are driven by intestinal stem cells (ISCs) that reside at the bottom of crypt and generate the precursors for the specialized differentiated cells (Barker, 2014; Li and Clevers, 2010). It has been extensively reported that ISC compartment includes two functionally and molecularly distinct stem cell populations (Barker, 2014; Li and Clevers, 2010; Gehart and Clevers, 2015): The active crypt base columnar (CBC) stem cells (Sato et al., 2011), (Barker et al., 2007) and a more dormant, reserve ISC population that reside above the crypt base and exhibit no Wnt pathway activity, also referred as +4 cells due to their position at the crypt (Montgomery et al., 2011; Sangiorgi and Capecchi, 2008; Tian et al., 2011; Takeda et al., 2011; Li et al., 2014; Yan et al., 2012). The CBCs often identified and isolated based on the expression of Lgr5, a Wnt target gene (Barker et al., 2007). During homeostasis, steady-state proliferation of CBCs is driven by extrinsic niche signals – high canonical Wnt activity promotes CBC self-renewal and proliferation (Barker et al., 2007; Miyoshi, 2017) while BMP signals antagonize it (Kosinski et al., 2007). In contrast to the active CBCs, the reserve ISCs represent a slow-cycling population of stem cells that are resistant to high doses of ionizing radiation and appear dispensable for homeostasis (Sangiorgi and Capecchi, 2008; Yousefi et al., 2016). These reserve ISCs are identified through CreERT knockin reporter alleles at the Bmi1 and Hopx loci, as well as by an Tert-CreERT transgene (Montgomery et al., 2011; Sangiorgi and Capecchi, 2008; Tian et al., 2011; Takeda et al., 2011; Li et al., 2014). Reserve ISCs do not have an active Wnt signaling pathway and are refractory to Wnt signals in their resting state (Takeda et al., 2011; Li et al., 2014; Li et al., 2016). Although the activity of the BMP pathway has never been directly examined specifically in reserve ISCs, indirect evidence suggests that it may help to promote their dormancy (Reynolds et al., 2014; He et al., 2004; Kishimoto et al., 2015). During epithelial regeneration upon stresses, reserve ISCs give rise to Wnthigh Lgr5+ CBCs that generate the precursor cells of the specialized differentiated cells (Tian et al., 2011; Takeda et al., 2011; Li et al., 2014). In addition, it has been documented that Lgr5-CreERT- or Bmi1-CreERT-marked cells can act as the cells of origin of intestinal cancer in mice (Sangiorgi and Capecchi, 2008; Barker et al., 2009). However, it remains unclear how ISCs differentially sense and respond to multiple signals under both physiological and pathological conditions, and whether these signals contribute to intestinal tumorigenesis. MicroRNAs represent a broad class of 18–22 nucleotide noncoding RNAs that negatively regulate the stability and translation of target mRNAs. Mounting evidence indicates that microRNAs play important roles in stress-activated pathways (Leung and Sharp, 2010; Mendell and Olson, 2012; Emde and Hornstein, 2014) and in control of somatic stem cell fate and tumorigenesis (Gangaraju and Lin, 2009; Sun and Lai, 2013; Yi and Fuchs, 2011). Hundreds of microRNAs have been identified in the intestinal epithelium (McKenna et al., 2010). Global ablation of microRNA activity through genetic deletion of the microRNA processing enzyme Dicer demonstrated that microRNAs are critical for homeostasis of intestinal epithelium (McKenna et al., 2010). Recently, numerous reports demonstrate that specific microRNAs play important roles in the complex intestinal immune system and in the epithelium during homeostasis including miR-155, miR-29, miR-122, miR-21, miR-146a and miR-143/145 (Runtsch et al., 2014). Particularly, miR-143/145 are essential for intestinal epithelial regeneration after injury, acting non cell-autonomously in sub-epithelial myofibroblasts (Chivukula et al., 2014), indicating potential importance of microRNA activity in intestinal regeneration. In the ISC compartment, the function of miR-31 is of a particular interest, as it becomes overexpressed in colorectal cancer (Bandrés et al., 2006; Cottonham et al., 2010; Wang et al., 2009; Yang et al., 2013) and increases during the progression of inflammation-associated intestinal neoplasia (Olaru et al., 2011). In addition, it has been reported that miR-31 is enriched in mammary stem/progenitor cells, suggesting a potential role in somatic stem cells (Ibarra et al., 2007). Here we utilized gain- and loss-of-function mouse models to show that a damage-responsive microRNA, miR-31 drives proliferative expansion of both active and dormant ISCs, and acts as an oncogene promoting intestinal tumorigenesis in different models. Our findings implicated miR-31 as a potential high-value therapeutic target for a broad range of intestinal regenerative disorders and cancers. Results MiR-31 expression pattern in intestine under physiologIcal and pathological conditions Elevated miR-31 expression has been previously observed in colorectal cancers (Bandrés et al., 2006; Cottonham et al., 2010; Wang et al., 2009; Yang et al., 2013), however its expression in normal intestinal epithelium, particularly in ISCs, remains unclear. To begin addressing a potential role for miR-31 in the intestinal epithelium and ISCs, first we examined its expression pattern in intestine. MiR-31 expression levels are the highest in the Lgr5-GFPhighcrypt base columnar stem cells, intermediate in Lgr5-GFPlow transit-amplifying cell population and the lowest in Lgr5-GFPneg populations (Figure 1A). Higher level of miR-31 was also found in Hopx+ reserve ISCs than that in bulk epithelial cells (Figure 1A), based on isolation with Hopx-CreERT;mTmG alleles from mice 15 hr after tamoxifen injection. Consistently, in situ hybridization revealed that miR-31 expression levels are generally higher in the crypts than villi. MiR-31 is predominantly expressed in the epithelial cells of intestinal crypt, including stem cells and transit amplifying cells (Figure 1B). Next, we examined miR-31 expression in response to intestinal injury. Mice were exposed to 12 Gy γ-IR and then miR-31 expression was examined at various timepoints during the recovery phase. MiR-31 levels transiently and markedly drop by 24 hours (coincident with full proliferative arrest/DNA damage response), and then sharply upregulated 48 hours post-γ-IR (during initiation of regenerative proliferation from the radioresistant ISCs), and then return to baseline levels within one week (after full recovery) (Figure 1C). In situ hybridization reveals miR-31 expressing cells to be located in the regenerative foci known to exhibit high Lgr5 expression and Wnt pathway activity (Figure 1D). Together, these data suggest a role for this microRNA in ISC-driven regeneration. Figure 1 with 8 supplements see all Download asset Open asset MiR-31 promotes turnover of intestinal epithelial cells. (A) Schematic picture of intestinal crypt showing Lgr5+ CBCs and Hopx+ cells. qRT-PCR for miR-31 in Lgr5-GFPhigh, Lgr5-GFPlow, Lgr5-GFPneg, Hopx- and Hopx+ sorted intestinal epithelial cells. n = 4 biological replicates. (B) In situ hybridization for miR-31 in the intestinal epithelium. Left panel, representative low magnification image (Scale bar: 200 μm); Middle panels, high magnification images indicated by dashed boxes in left panel; Right panels (Scale bar: 50 μm), miR-31 KO intestinal section used as a negative control (Top) and TRE-miR31 (miR-31 overexpressing) intestinal section used as a positive control (Bottom). (C) qRT-PCR for miR-31 in the intestinal epithelium after exposure to 12 Gy γ-IR at indicated time points. n = 3 biological replicates. (D) In situ hybridization for miR-31 in intestines without γ -IR treatment (non-IR), and intestines 4 days after 12 Gy γ-IR. Arrows, miR-31 positive regenerative foci. Dashes boxes indicate the high magnification images in right panels. Scale bar: 50 μm. (E) Quantification of body weight from M2rtTA and TRE-miR31 mice at the age of 8 weeks before and after Dox treatment for 2 weeks. Quantification of intestine length from M2rtTA and TRE-miR31 mice following 2 week Dox induction. n = 6 biological replicates. ***p<0.001. (F) Representative histologic images showing extension of crypt height in jejunum from TRE-miR31 mice, and quantification of crypt height from M2rtTA and TRE-miR31 intestine. Both M2rtTA and TRE-miR31 mice were treated with Dox for 2 weeks. n = 3 biological replicates. Scale bar: 50 μm. ***p<0.001. (G) Immunohistochemistry for Ki67 and quantification of Ki67+ cells per crypt in M2rtTA andTRE-miR31 jejunum, showing an expanded proliferative zone in TRE-miR31 mice following 2 weeks of Dox induction. n = 3 biological replicates. Scale bar: 50 μm. ***p<0.001. (H) Immunohistochemistry for cleaved-Caspase 3 (Casp3) and quantification of Casp3+ cells in the top of intestinal villi from M2rtTA andTRE-miR31 mice following 2 weeks of Dox induction. n = 3 biological replicates. 60 villi were quantified in each mouse. Scale bar: 100 μm. ***p<0.001. (I) Representative histologic images and quantification of crypt height in intestines from miR-31+/− and miR-31−/− mice at 2 months of age. Brackets mark crypts. Scale bar: 100 μm. n = 3 biological replicates. ***p<0.001. https://doi.org/10.7554/eLife.29538.003 Figure 1—source data 1 Source data for Figure 1C,E,F,G,H and I. https://doi.org/10.7554/eLife.29538.012 Download elife-29538-fig1-data1-v1.xlsx Figure 1—source data 2 Source data for Figure 1—figure supplements 1–3. https://doi.org/10.7554/eLife.29538.013 Download elife-29538-fig1-data2-v1.xlsx Figure 1—source data 3 Source data for Figure 1—figure supplements 4–7. https://doi.org/10.7554/eLife.29538.014 Download elife-29538-fig1-data3-v1.xlsx MiR-31 promotes intestinal epithelial cell turnover along the Crypt-villus axis To determine the function of miR-31 in the mouse intestine, we generated both gain- and loss- of-function mouse models. MiR-31 gain-of-function was achieved with a targeted, inducible Rosa26-rtTA;TRE-miR-31 mouse model (TRE-miR31) and doxycycline (Dox)-mediated induction of miR-31 in the intestinal epithelium was validated by qRT-PCR (Figure 1—figure supplement 1A,B). For the loss-of-function, we generated constitutive miR-31 null mice using RNA-guided CRISPR/Cas9 nucleases (Figure 1—figure supplement 1C). The 402 bp DNA fragment containing miR-31 was deleted in the knockout (KO) allele (Figure 1—figure supplement 1D), which was validated by sequencing and qRT-PCR (Figure 1—figure supplement 1E). We also generated a Villin-Cre-mediated intestine-specific conditional miR-31 null mice (cKO) using traditional homology-directed gene targeting (Figure 1—figure supplement 1F). The expression of miR-31 was markedly reduced in the cKO intestinal epithelium (Figure 1—figure supplement 1G). The induction of miR-31 in TRE-miR31 intestine and deletion of miR-31 in KO intestine were also confirmed by in situ hybridization (Figure 1—figure supplement 1H). MiR-31 induction in response to Dox administration in TRE-miR31 mice resulted in a significant reduction in body weight after 2 weeks (Figure 1E) and intestinal lengths were moderately, but significantly shorter than controls (Figure 1E). Dox treatment of TRE-miR31 mice for 2 weeks resulted in expansion of intestinal crypts (Figure 1F). Unexpectedly villus lengths were mildly shortened, and thus the total length of the crypt-villus was not significantly altered in TRE-miR31 mice (Figure 1—figure supplement 2A). The expanded crypts were also found in the TRE-miR31 duodenum and ileum (Figure 1—figure supplement 2B). The length of intestinal crypts in the control M2rtTA mice was not significantly altered at different time points in response to Dox treatment (Figure 1—figure supplement 2C,D). In contrast, crypts were significantly expanded in TRE-miR31 mice after 10 days of Dox treatment, this crypt expansion remained stable for up to 1 year with continuous Dox induction (Figure 1—figure supplement 2C–E). Given that crypt elongation reached maximal levels within 2 weeks of Dox induction, we conducted most of the subsequent assays at this time point. More mitotic cells were found in the TRE-miR31 crypts (Figure 1G and Figure 1—figure supplement 3A,B), while more apoptotic cells were detected at the top of TRE-miR31 villi (Figure 1H and Figure 1—figure supplement 3A,B). The number of Lgr5+ ISCs increased in TRE-miR31 mice after 10 day Dox treatment, while no significant difference was found between them after 7 days of Dox induction (Figure 1—figure supplement 3C,D). In addition, there were fewer differentiated cells including enteroendocrine, goblet and Paneth cells in TRE-miR31 intestine than the controls (Figure 1—figure supplement 4A,B), indicating an impaired cell differentiation. These results suggest that miR-31 induction accelerates the conveyer-belt movement of proliferative cells exiting the cell cycle and progressing into the villi to ultimately be shed into the lumen, which could comprise the differentiation of specialized intestinal cell types. Next, we examined the consequence of miR-31 loss in both miR-31 germline knockout (KO) and Villin-Cre-driven intestinal epithelial conditional KO (cKO) mice. We followed these mice up to six months. Both miR-31 KO and cKO mice were viable and fertile with no apparent gross phenotypes observed. No differences in the body weight and intestinal length were found between control and miR-31 KO mice (Figure 1—figure supplement 5A), and the transmission of miR-31 knockout alleles generally followed Mendelian ratios (Figure 1—figure supplement 5B). Despite this, loss of miR-31 led to a significant reduction in crypt height with fewer proliferative cells (Figure 1I and Figure 1—figure supplement 5C,D). Interestingly, loss of miR-31 gave rise to a certain number of apoptotic cells throughout the crypt-villus axis, while apoptotic cells are predominantly presented at the tip of control villi and very rare apoptotic cells are presented in crypt-villus axis (Figure 1—figure supplement 5C,D). Deletion of miR-31 also led to increased numbers of enteroendocrine and Paneth cells, while the number of goblet cells remained unaltered in miR-31 KO intestines (Figure 1—figure supplement 6A,B). Moreover, the phenotype of shortened crypts with fewer proliferative cells was also found in cKO intestine (Figure 1—figure supplement 7A,B). Loss of miR-31 gave rise to more apoptotic cells in cKO intestinal epithelium, including in cKO crypts, while cleaved-caspase3+ apoptotic cells were nearly entirely absent from control crypts (Figure 1—figure supplement 7C,D). These results suggest that miR-31 loss functions within intestinal epithelium. We further analyzed DNA synthesis and migration of epithelial cells along the crypt-villus axis after a single pulse of BrdU. Upward movement of BrdU+ cells from crypts to villi was enhanced in TRE-miR31 mice, and this movement was impaired in miR-31−/− mice (Figure 1—figure supplement 8). Taken together, these data indicate that miR-31 functions within the intestinal epithelium to maintain a proper balance between stem cell proliferation, differentiation, and epithelial cell death for optimal intestinal homeostasis. MiR-31 promotes expansion of Lgr5+ CBC stem cells Higher expression levels of miR-31 in Lgr5+ CBCs prompted us to examine its effect on their renewal. Lgr5+ ISC frequency was markedly increased in TRE-miR31, and significantly reduced in miR-31−/− and cKO intestine (Figure 2A–C and Figure 2—figure supplement 1A). A 1.5 hr pulse of EdU incorporation demonstrated that the frequency of actively proliferating Lgr5-GFP+/EdU+ cells is higher in TRE-miR31 mice and conversely lower in miR-31−/− mice (Figure 2D). In line with these in vivo findings, miR-31 induction increased the frequency of budding organoids in vitro, and caused more buds per organoid and more elongated crypts (Figure 2E and Figure 2—figure supplement 1B). Furthermore, lineage-tracing assay reveals that miR-31 induction in the intestine increases the height of traced lineages derived from Lgr5-CreERT-marked ISCs (Figure 2F,G and Figure 2—figure supplement 1C). Interestingly, miR-31 induction significantly repressed Hopx expression, while deletion of miR-31 increased it (Figure 2H). Consistently, miR-31 induction in the intestine repressed lineage tracing from Hopx-CreERT-marked reserve ISCs (Figure 2I, and Figure 2—figure supplement 1D,E). In contrast to miR-31 overexpression, deletion of miR-31 within intestinal epithelium induced quiescence (residence in G0) in Lgr5-GFP+ cells concomitant to an increase in apoptosis and a decrease in cycling (G1/S/G2/M) (Figure 2J and Figure 2—figure supplement 1F). In agreement, higher frequency of apoptotic organoids and compromised budding was found in the cKO crypts (Figure 2K), and more apoptotic cells were found inside of the cKO organoids (Figure 2—figure supplement 1G). Taken together, these data strongly indicate that miR-31 promotes proliferative expansion of Lgr5+ CBCs, and concomitantly prevents their apoptosis. Figure 2 with 1 supplement see all Download asset Open asset MiR-31 promotes expansion of Lgr5+ CBC stem cells. (A) Representative FACS profiles and quantification of GFP positive intestinal epithelial cells (Lgr5-GFP+ cells) from an Lgr5-eGFP-CreERT reporter mice crossed with M2rtTA (control) and TRE-miR31 mice. M2rtTA (control) and TRE-miR31 mice were pre-treated with Dox for two weeks. n = 4 biological replicates. ***p<0.001. (B, C) FACS profiles and quantification of Lgr5-GFP+ cells from an Lgr5-eGFP-CreER reporter mice crossed with miR-31+/− (control) and miR-31−/− mice (B), or Vil-Cre (Villin-Cre) and cKO (Vil-Cre;miR-31fl/fl) mice (C). n = 4 biological replicates. ***p<0.001. (D) Assessment of 1.5-hour-pulse EdU incorporation in Lgr5+ CBC cells in M2rtTA, and TRE-miR31 mice following 2 weeks of Dox treatment, and in miR-31+/− and miR-31−/− intestine. ***p<0.001. (E) Crypts purified from M2rtTA and TRE-miR31 mice grown in organoid cultures with Dox. Representative gross images of budding organoids, and quantification of budding and apoptotic organoids at day 7. Scale bar: 500 μm. n = 5 technical replicates. (F) X-gal staining showing lineage tracing events from Lgr5+ ISCs. Lgr5-eGFP-CreERT;R26-LSL-LacZ;TRE-miR31 mice and its control counterpart were pretreated with Dox for 2 weeks, injected with a single dose tamoxifen, and analyzed 2 and 4 days after injection. Scale bar: 100 μm. n = 3 biological replicates. (G) Quantification of the length of LacZ+ cells and LacZ+ units in Panel F. ***p<0.001. (H) qRT-PCR analysis for Hopx in intestines from M2rtTA, TRE-miR31, Vil-Cre and cKO mice. n = 3 biological replicates. **p<0.01; ***p<0.001. (I) Lineage tracing events from Hopx+ ISCs. Hopx-CreERT;mTmG;TRE-miR31 mice and their control counterparts were pretreated with Dox for 2 weeks, injected with a single dose of tamoxifen, and analyzed 15 hr after injection. Hopx-CreERT;R26-LSL-LacZ;TRE-miR31 and their control counterparts were analyzed 4 days after inject with the same treatment. Scale bar: 100 μm. n = 3 biological replicates. (J) Quantification of Cleaved Caspase3+ cells at indicated positions in the intestinal crypts of Vil-Cre and miR-31 cKO mice in Figure 1—figure supplement 7D. n = 3 biological replicates, 50 crypts per sample. (K) Crypts purified from Vil-Cre and miR-31 cKO mice grown in organoid cultures at indicated time points. Quantification of budding organoids and apoptotic organoids, budding number and crypt length. n = 3 biological replicates. ***p<0.001. https://doi.org/10.7554/eLife.29538.015 Figure 2—source data 1 Source data for Figure 2. https://doi.org/10.7554/eLife.29538.017 Download elife-29538-fig2-data1-v1.xlsx Figure 2—source data 2 Source data for Figure 2—figure supplement 1. https://doi.org/10.7554/eLife.29538.018 Download elife-29538-fig2-data2-v1.xlsx MiR-31 is critical for intestinal epithelial regeneration following irradiation The dynamic changes of miR-31 expression in response to irradiation prompted us to investigate its function during intestinal epithelial injury repair. Intestinal histology of cKO and control Vil-Cre mice was comparable two hours after 12 Gy γ-IR (Figure 3A). However, by 4 days post-γ-IR, there were significantly fewer regenerative foci and fewer proliferative cells per regenerative focus in cKO mice (Figure 3A). Consistently, intestinal regeneration in response to γ-IR was significantly impaired in miR-31−/− mice (Figure 3—figure supplement 1A,B). Conversely, in the intestine of TRE-miR31 mice pre-treated for 2 weeks with Dox, there were more regenerative foci with higher numbers of proliferative cells than in the control mice (Figure 3—figure supplement 1A,B). These data suggest that miR-31 is important for intestinal epithelial regeneration in response to irradiation. Figure 3 with 1 supplement see all Download asset Open asset Loss of miR-31 abrogates epithelial regeneration following irradiation. (A) Representative images of H&E and/or Ki67 immunohistochemistry from jejunum of irradiated Vil-Cre and cKO mice 2 hrs and 4 days post 12 Gy γ-IR. Quantification of Ki67+ regenerative foci per 1400 μm and No. of Ki67+ cells per regenerative focus. Top panel: n = 6 biological replicates; Scale bar: 200 μm. Middle and bottom panels: n = 5 biological replicates; Scale bar: 50 μm. **p<0.01; ***p<0.001. (B) Immunohistochemistry for Casp3, quantification of the number of Casp3+ cells in intestinal crypts of Vil-Cre and cKO mice 2 and 4 hrs post 12 Gy γ-IR. Quantification of Casp3+ cells at indicated positions in intestinal crypts of Vil-Cre and cKO mice 2 hrs post γ-IR. Scale bar: 50 μm. n = 3 biological replicates, and 50 crypts were quantified in each single mouse. ***p<0.001. (C) qRT-PCR analysis for Lgr5 in intestines from M2rtTA, TRE-miR31, miR-31+/− and miR-31−/− mice 2 hrs, 2 and 4 days post 12 Gy irradiation. M2rtTA and TRE-miR31 mice were pre-treated with Dox for two weeks. n = 3 biological replicates at each time points. *p<0.05; **p<0.01; ***p<0.001. (D) Schematic of Lgr5-eGFP-CreERT;R26-LSL-LacZ lineage tracing experiment after irradiation. X-gal staining showing lineage tracing events from Lgr5+ ISCs. Lgr5-eGFP-CreERT;R26-LSL-LacZ;TRE-miR31 mice and their control counterparts were pretreated with Dox for 2 weeks, injected with a single dose tamoxifen and then immediately exposed to 10 Gy γ-IR, and analyzed 2 and 4 days after γ-IR. Scale bar: 100 μm. n = 3 biological replicates at each time points. (E) Quantification of LacZ+ units and the length of LacZ+ cells in Panel D. (F) Schematic of Hopx-CreERT;R26-LSL-LacZ lineage tracing experiment. Hopx-CreERT;R26-LSL-LacZ;TRE-miR31 and their control counterparts were pretreated with Dox for 2 weeks, then injected with a single dose of tamoxifen, and then irradiated 15 hrs after injection and analyzed 4 days after irradiation. Representative images of LacZ staining in M2rtTA and TRE-miR31 intestine 4 days post 12 Gy γ-IR. Scale bar: 50 μm. Statistics of LacZ+ regenerative foci were shown in Figure 3—figure supplement 1E. n = 3 biological replicates. (G) Schematic of Hopx-CreERT;R26-LSL-LacZ lineage tracing experiment. Representative images of LacZ staining in miR-31+/− and miR-31−/− intestine 4 days post 12 Gy γ-IR. Scale bar: 50 μm. Statistics of LacZ+ regenerative foci. n = 3 biological replicates. (H) Representative images of LacZ (blue) and Ki67 (yellow) immunostaining in miR-31+/− and miR-31−/− intestinal crypts, and statistics of percentage of LacZ+/Ki67+cells in regenerative foci. Scale bar: 25 μm. n = 3 biological replicates. ***p<0.001. https://doi.org/10.7554/eLife.29538.019 Figure 3—source data 1 Source data for Figure 3. https://doi.org/10.7554/eLife.29538.021 Download elife-29538-fig3-data1-v1.xlsx Figure 3—source data 2 Source data for Figure 3—figure supplement 1. https://doi.org/10.7554/eLife.29538.022 Download elife-29538-fig3-data2-v1.xlsx To understand the phenotype resulting from miR-31 modulation, we assayed for apoptotic cells in cKO mice at early stages after irradiation. Loss of miR-31 increased apoptosis in the crypts 2 and 4 hours post-irradiation prior to any overt histological changes (Figure 3B). Quantification of apoptotic cell position analysis reveals that apoptotic events occur with the highest frequently in CBC cells, but are still found in transit-amplifying and +4 zones of cKO crypts, compared to control mice (Figure 3B). Further, flow cytometry for live cell and apoptotic markers within the Lgr5-GFP+ population confirmed higher frequency of late apoptotic Lgr5+ cells (AnnexinV+/7AAD+) and lower frequency of early apoptotic Lgr5+ cells (AnnexinV+/7AAD−) and live Lgr5+ cells (AnnexinV-/7AAD-) in cKO mice, relative to controls (Figure 3—figure supplement 1C). These data suggest